Screener
Evolent Health, Inc. EVH EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Evolent Health, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Evolent Health, Inc.’s 10-Q, filed November 7, 2025. Open the filing →
- Filed
- Nov 7, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001628908-25-000133
FAQ
- What is Evolent Health, Inc.'s EV / EBITDA?
- Evolent Health, Inc. (EVH) reported EV / EBITDA of 24.5× in Q3 2025.
- How has Evolent Health, Inc.'s EV / EBITDA changed year-over-year?
- Evolent Health, Inc.'s EV / EBITDA decreased by 51.8% year-over-year, from 50.7× to 24.5×.
- What is the long-term trend for Evolent Health, Inc.'s EV / EBITDA?
- Over 3 years (2021 to 2024), Evolent Health, Inc.'s EV / EBITDA has grown at a -44.3% compound annual growth rate (CAGR), from 141.2× to 24.4×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about Evolent Health, Inc.'s ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude